Generic Reform Advocates See Reimport Bill As Model: Is Hatch Obstacle?
Executive Summary
Waxman/Hatch reform legislation could move in the 107th Congress in a fashion similar to the reimportation bill enacted in 2000, Generic Pharmaceutical Association President William Nixon suggested during the Schwab Washington Research Group healthcare conference in Washington, D.C. May 9.
You may also be interested in...
Waxman/Hatch Reform Should Await Pending Supreme Court Decision – Hatch
Congress should wait for an upcoming Supreme Court ruling on the "doctrine of equivalents" before beginning serious work on re-drafting the Waxman/Hatch Act, Sen. Orrin Hatch (R-Utah) said
Waxman/Hatch Reform Should Await Pending Supreme Court Decision – Hatch
Congress should wait for an upcoming Supreme Court ruling on the "doctrine of equivalents" before beginning serious work on re-drafting the Waxman/Hatch Act, Sen. Orrin Hatch (R-Utah) said
Patent Extensions’ Cost To Be Evaluated By FDA Under Ag Approps Request
FDA will report on the costs to consumers of drug patent extensions by March